Amgen News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

28.10.05	European Commission Approves Kepivance(TM) (Palifermin) for Oral Mucositis in Cancer Patients Undergoing Blood and Bone Marrow Transplant (Businesswire)
19.10.05	Amgen's Third Quarter 2005 Adjusted Earnings Per Share Increased 33 Percent to 85 Cents; Third Quarter 2005 GAAP Earnings Per Share Increased to 77 Cents from 18 Cents (Businesswire)
15.09.05	FDA Expands Neulasta(R) Label; New Label Extends First-Cycle Protection From Infection To Cancer Patients Receiving Moderately Myelosuppressive Chemotherapy (Businesswire)
02.09.05	Amgen Names Phyllis Piano Vice President, Corporate Communications and Philanthropy (Businesswire)
02.09.05	Amgen Announces Initiation of Phase 3 Trial to Evaluate the Impact of Treating Anemia with Darbepoetin Alfa in Patients with Heart Failure to Reduce Mortality and Hospitalization (Businesswire)
10.08.05	Amgen Names Michael Kelly as Chief Accounting Officer (Businesswire)
01.08.05	Abgenix and Amgen Announce FDA Grants Panitumumab Fast Track Designation for Metastatic Colorectal Cancer (Businesswire)
15.05.05	Large Community-Based Clinical Trial in Older Cancer Patients Suggests (Businesswire)
15.05.05	Final Results of Phase 3 Head-to-Head Study Demonstrate Aranesp Dosed (Businesswire)
15.05.05	Aranesp Dosed Every Three Weeks Achieved and Maintained Target Hemoglo (Businesswire)
06.05.05	Amgen Submits Supplemental Biologics License Application for Aranesp E (Businesswire)
05.05.05	Amgen Announces One-Day Extension of Its Exchange Offer for Its Outsta (Businesswire)
03.05.05	Amgen Announces Plans to Webcast Selected Management Presentations (Businesswire)
21.04.05	Amgen's First Quarter 2005 Adjusted Earnings Per Share Increased 26 P (Businesswire)
04.04.05	Amgen Announces Webcast of First Quarter Financial Results (Businesswire)
28.03.05	Landmark Trial Will Evaluate the Impact of Treating Anemia on Cardiova (Businesswire)
25.02.05	Phase 3 Study Published in The Journal of Clinical Oncology Shows Firs (Businesswire)
11.02.05	Following Complete Review of Phase 2 Trial Data Amgen Confirms Decisio (Businesswire)
31.01.05	Amgen Announces Put Option Notification for Liquid Yield Option Notes (Businesswire)
27.01.05	Amgen's Fourth Quarter 2004 Adjusted Earnings Per Share Increased 26 (Businesswire)
22.01.05	Amgen Announces Webcast of 2004 Fourth Quarter and Full Year Financial (Businesswire)
11.01.05	Amgen Significantly Expands Support of Patient Assistance Programs; Fi (Businesswire)
04.01.05	Amgen Donates $1 Million and Establishes Tsunami Relief Program; Staff (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Dow Jones aktuell: Dow Jones fällt zum Start des Freitagshandels zurück
20.12.24		NASDAQ-Handel NASDAQ 100 schwächelt zum Start des Freitagshandels
20.12.24		Börse Frankfurt: So steht der LUS-DAX am Nachmittag
20.12.24		Börse Frankfurt: DAX präsentiert sich nachmittags leichter
20.12.24		Zurückhaltung in Europa: Euro STOXX 50 präsentiert sich schwächer
20.12.24		Wechsel bei Sanofi: Ex-Morphosys-Chef Kress tritt in den Verwaltungsrat ein -Sanofi-Aktie tiefer